Chugai Pharmaceutical Co., Ltd.

2:15 PM - 2:30 PM, Tuesday, June 4, 2019 ・ Theater 1
Chugai Pharmaceutical is one of Japan’s leading research-based pharmaceutical companies with strengths in biotechnology products. Chugai, based in Tokyo, specializes in prescription Pharmaceuticals and is listed on the 1st section of the Tokyo Stock Exchange. As an important member of the Roche Group, Chugai is actively involved in R&D activities in Japan and abroad. Specifically, Chugai is working to develop innovative products which may satisfy the unmet medical needs, mainly focusing on the oncology area.
Ticker:
4519
Exchange:
First Section of Tokyo Stock Exchange
Company Type:
Company HQ State:
Not Provided.
Company HQ Country:
Japan
Year Founded:
Not Provided.
Main Therapeutic Focus:
Lead Product in Development:
satralizumab, nemolizumab, SKY59
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided.